227 related articles for article (PubMed ID: 22642414)
1. Treatment outcomes for methamphetamine users receiving outpatient counselling from the Stimulant Treatment Program in Australia.
McKetin R; Dunlop AJ; Holland RM; Sutherland RA; Baker AL; Salmon AM; Hudson SL
Drug Alcohol Rev; 2013 Jan; 32(1):80-7. PubMed ID: 22642414
[TBL] [Abstract][Full Text] [Related]
2. Methamphetamine treatment outcomes among gay men attending a LGBTI-specific treatment service in Sydney, Australia.
Lea T; Kolstee J; Lambert S; Ness R; Hannan S; Holt M
PLoS One; 2017; 12(2):e0172560. PubMed ID: 28207902
[TBL] [Abstract][Full Text] [Related]
3. Characteristics and harms associated with injecting versus smoking methamphetamine among methamphetamine treatment entrants.
McKetin R; Ross J; Kelly E; Baker A; Lee N; Lubman DI; Mattick R
Drug Alcohol Rev; 2008 May; 27(3):277-85. PubMed ID: 18368609
[TBL] [Abstract][Full Text] [Related]
4. Dose-related psychotic symptoms in chronic methamphetamine users: evidence from a prospective longitudinal study.
McKetin R; Lubman DI; Baker AL; Dawe S; Ali RL
JAMA Psychiatry; 2013 Mar; 70(3):319-24. PubMed ID: 23303471
[TBL] [Abstract][Full Text] [Related]
5. Effect of prize-based incentives on outcomes in stimulant abusers in outpatient psychosocial treatment programs: a national drug abuse treatment clinical trials network study.
Petry NM; Peirce JM; Stitzer ML; Blaine J; Roll JM; Cohen A; Obert J; Killeen T; Saladin ME; Cowell M; Kirby KC; Sterling R; Royer-Malvestuto C; Hamilton J; Booth RE; Macdonald M; Liebert M; Rader L; Burns R; DiMaria J; Copersino M; Stabile PQ; Kolodner K; Li R
Arch Gen Psychiatry; 2005 Oct; 62(10):1148-56. PubMed ID: 16203960
[TBL] [Abstract][Full Text] [Related]
6. Crystal methamphetamine smoking among regular ecstasy users in Australia: increases in use and associations with harm.
Kinner SA; Degenhardt L
Drug Alcohol Rev; 2008 May; 27(3):292-300. PubMed ID: 18368611
[TBL] [Abstract][Full Text] [Related]
7. Methamphetamine use, dependence and treatment access in rural and regional North Coast of New South Wales, Australia.
Wallace C; Galloway T; McKetin R; Kelly E; Leary J
Drug Alcohol Rev; 2009 Nov; 28(6):592-9. PubMed ID: 19930011
[TBL] [Abstract][Full Text] [Related]
8. Barriers to methamphetamine withdrawal treatment in Australia: findings from a survey of AOD service providers.
Pennay AE; Lee NK
Drug Alcohol Rev; 2009 Nov; 28(6):636-40. PubMed ID: 19930017
[TBL] [Abstract][Full Text] [Related]
9. Socio-demographic factors associated with methamphetamine treatment contact among dependent methamphetamine users in Sydney, Australia.
McKetin R; Kelly E
Drug Alcohol Rev; 2007 Mar; 26(2):161-8. PubMed ID: 17364851
[TBL] [Abstract][Full Text] [Related]
10. Behavioral treatment approaches for methamphetamine dependence and HIV-related sexual risk behaviors among urban gay and bisexual men.
Shoptaw S; Reback CJ; Peck JA; Yang X; Rotheram-Fuller E; Larkins S; Veniegas RC; Freese TE; Hucks-Ortiz C
Drug Alcohol Depend; 2005 May; 78(2):125-34. PubMed ID: 15845315
[TBL] [Abstract][Full Text] [Related]
11. The epidemiology of methamphetamine use and harm in Australia.
Degenhardt L; Roxburgh A; Black E; Bruno R; Campbell G; Kinner S; Fetherston J
Drug Alcohol Rev; 2008 May; 27(3):243-52. PubMed ID: 18368605
[TBL] [Abstract][Full Text] [Related]
12. Hostility among methamphetamine users experiencing psychotic symptoms.
McKetin R; McLaren J; Lubman DI; Hides L
Am J Addict; 2008; 17(3):235-40. PubMed ID: 18464001
[TBL] [Abstract][Full Text] [Related]
13. Randomized controlled trial of dexamphetamine maintenance for the treatment of methamphetamine dependence.
Longo M; Wickes W; Smout M; Harrison S; Cahill S; White JM
Addiction; 2010 Jan; 105(1):146-54. PubMed ID: 19839966
[TBL] [Abstract][Full Text] [Related]
14. The prevalence of psychotic symptoms among methamphetamine users.
McKetin R; McLaren J; Lubman DI; Hides L
Addiction; 2006 Oct; 101(10):1473-8. PubMed ID: 16968349
[TBL] [Abstract][Full Text] [Related]
15. The matrix model of outpatient stimulant abuse treatment: history and description.
Obert JL; McCann MJ; Marinelli-Casey P; Weiner A; Minsky S; Brethen P; Rawson R
J Psychoactive Drugs; 2000; 32(2):157-64. PubMed ID: 10908003
[TBL] [Abstract][Full Text] [Related]
16. Brief cognitive behavioural interventions for regular amphetamine users: a step in the right direction.
Baker A; Lee NK; Claire M; Lewin TJ; Grant T; Pohlman S; Saunders JB; Kay-Lambkin F; Constable P; Jenner L; Carr VJ
Addiction; 2005 Mar; 100(3):367-78. PubMed ID: 15733250
[TBL] [Abstract][Full Text] [Related]
17. Depression ratings, reported sexual risk behaviors, and methamphetamine use: latent growth curve models of positive change among gay and bisexual men in an outpatient treatment program.
Jaffe A; Shoptaw S; Stein J; Reback CJ; Rotheram-Fuller E
Exp Clin Psychopharmacol; 2007 Jun; 15(3):301-7. PubMed ID: 17563217
[TBL] [Abstract][Full Text] [Related]
18. Poly-drug and marijuana use among adults who primarily used methamphetamine.
Herbeck DM; Brecht ML; Lovinger K; Raihan A; Christou D; Sheaff P
J Psychoactive Drugs; 2013; 45(2):132-40. PubMed ID: 23909001
[TBL] [Abstract][Full Text] [Related]
19. A double-blind, placebo-controlled trial of modafinil (200 mg/day) for methamphetamine dependence.
Shearer J; Darke S; Rodgers C; Slade T; van Beek I; Lewis J; Brady D; McKetin R; Mattick RP; Wodak A
Addiction; 2009 Feb; 104(2):224-33. PubMed ID: 19149817
[TBL] [Abstract][Full Text] [Related]
20. Does methamphetamine use increase violent behaviour? Evidence from a prospective longitudinal study.
McKetin R; Lubman DI; Najman JM; Dawe S; Butterworth P; Baker AL
Addiction; 2014 May; 109(5):798-806. PubMed ID: 24400972
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
